Update on Rifampin and Rifabutin Drug Interactions

This publication has 65 references indexed in Scilit:

• Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen
  Journal of Antimicrobial Chemotherapy, 2006
• Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphism
  British Journal of Clinical Pharmacology, 2005
• Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol
  Clinical Pharmacokinetics, 2005
• Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer
  International Journal of Clinical Oncology, 2004
• Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects
  British Journal of Clinical Pharmacology, 2003
• Rifamycin Treatment of Tuberculosis in a Patient Receiving Atenolol: Less Interaction with Rifabutin than with Rifampin
  Clinical Infectious Diseases, 2003
• A Regimen Containing Rifabutin for the Treatment of Tuberculosis in Patients Intolerant to Rifampin
  Clinical Infectious Diseases, 2003
• Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride
  British Journal of Clinical Pharmacology, 2000
• Comparison of High and Low Doses of Trimethoprim-Sulfamethoxazole for Primary Prevention of Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients
  Clinical Infectious Diseases, 1999
• Rifampin Drug Interactions
  Archives of internal medicine (1960), 1984